Old Web
English
Sign In
Acemap
>
authorDetail
>
Rachel Moate
Rachel Moate
MedImmune
Immunology
Tralokinumab
Medicine
Atopic dermatitis
Rheumatoid factor
3
Papers
225
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
2019
The Journal of Allergy and Clinical Immunology
Andreas Wollenberg
Michael D. Howell
Emma Guttman-Yassky
Jonathan I. Silverberg
Christopher Kell
Koustubh Ranade
Rachel Moate
René van der Merwe
Show All
Source
Cite
Save
Citations (186)
A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity
2019
Science Translational Medicine
Jodi L. Karnell
Marius Albulescu
Stacey Drabic
L. Wang
Rachel Moate
Manuel Baca
Vaheh Oganesyan
Michele Gunsior
Thomas Thisted
Li Yan
Jing Li
Ximing Xiong
Steven Eck
Melissa de los Reyes
Isharat Yusuf
Katie Streicher
Ulf-Müller Ladner
David Howe
Rachel Ettinger
Ronald Herbst
Jorn Drappa
Show All
Source
Cite
Save
Citations (39)
Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
2018
The Journal of Allergy and Clinical Immunology
Andreas Wollenberg
Michael D. Howell
Emma Guttman-Yassky
Jonathan I. Silverberg
Christopher Kell
Koustubh Ranade
Rachel Moate
René van der Merwe
Show All
Source
Cite
Save
Citations (0)
1